scholarly article | Q13442814 |
P50 | author | Randy Quentin Cron | Q41541880 |
Fabrizio De Benedetti | Q56394747 | ||
Purvesh Khatri | Q57163305 | ||
Ying Lu | Q59747997 | ||
Gill Bejerano | Q88164421 | ||
Elizabeth D Mellins | Q89700108 | ||
Edward M Behrens | Q90341329 | ||
Dieneke Schonenberg-Meinema | Q92921580 | ||
P2093 | author name string | Johannes Roth | |
Diana Milojevic | |||
Karen Onel | |||
Lisa R Young | |||
Matthew L Stoll | |||
Rayfel Schneider | |||
Richard K Vehe | |||
Sampath Prahalad | |||
Mark M Davis | |||
Christi J Inman | |||
Lu Tian | |||
Sara O Vargas | |||
Judith A Smith | |||
Jianpeng Xu | |||
Tushar Desai | |||
Seza Ozen | |||
Marisa Klein-Gitelman | |||
Melissa Hazen | |||
Alexei A Grom | |||
Gail H Deutsch | |||
Susan Shenoi | |||
Robin Deterding | |||
Maria Perez | |||
R Paul Guillerman | |||
Kevin Baszis | |||
T Brent Graham | |||
Christopher Towe | |||
Jenny Lin | |||
Deborah R Liptzin | |||
Hafize Emine Sönmez | |||
Alicia Casey | |||
Maria Ibarra | |||
Raymond Balise | |||
Ann N Leung | |||
Aliva De | |||
Vivian E Saper | |||
Ian Ferguson | |||
Johannes Birgmeier | |||
Clara Lin | |||
Lauren A Henderson | |||
Guangbo Chen | |||
Martha P Fishman | |||
Childhood Arthritis and Rheumatology Research Alliance Registry Investigators | |||
Grant Schulert | |||
Layla Bouzoubaa | |||
Daniel J Kingsbury | |||
Sivia Lapidus | |||
Rita Jerath | |||
Khalid Abulaban | |||
Kathleen Haines | |||
Adam Reinhardt | |||
Karthik Jagadeesh | |||
Suhas Radhakrishna | |||
Scott Canna | |||
Jacqueline Yang | |||
James Birmingham | |||
Assunta Ho | |||
Joy Mombourquette | |||
Kathryn Phillippi | |||
Khanh Lai | |||
Khulood Khawaja | |||
Michal Cidon | |||
Mona Riskalla | |||
Natalie Rosenwasser | |||
Steven I Goodman | |||
P2860 | cites work | Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis | Q24610145 |
Genetic disorders of surfactant dysfunction | Q28235256 | ||
Endogenous lipoid pneumonia preceding diagnosis of pulmonary alveolar proteinosis | Q28245541 | ||
Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). | Q31140276 | ||
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis | Q33404895 | ||
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months | Q33568429 | ||
Age-dependent levels of select immunological mediators in sera of healthy children | Q33992976 | ||
Pulmonary alveolar proteinosis: progress in the first 44 years | Q34139014 | ||
Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis | Q34239936 | ||
Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans | Q34475541 | ||
Diffuse lung disease in young children: application of a novel classification scheme | Q34691602 | ||
The role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells. | Q34749235 | ||
Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study | Q35035794 | ||
Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis | Q35064189 | ||
Pathologic characteristics of drug-induced lung disease | Q35736979 | ||
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis | Q35766646 | ||
Abdominal and pelvic CT in the HIV-positive population | Q35936526 | ||
Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island | Q36060847 | ||
Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. | Q36131723 | ||
Interleukin 1: an important mediator of host resistance against Pneumocystis carinii | Q36231708 | ||
Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome | Q36425766 | ||
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. | Q36979961 | ||
Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. | Q36979986 | ||
Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review | Q37605617 | ||
Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome | Q37770687 | ||
Infections and immunodeficiency in Down syndrome | Q37847219 | ||
Thoracic findings of systemic diseases at high-resolution CT in children | Q37854279 | ||
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? | Q37871716 | ||
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease | Q38006923 | ||
Diffuse and interstitial lung disease and childhood rheumatologic disorders | Q38028313 | ||
Pulmonary complications of biological therapies in children and adults with rheumatic diseases. | Q38086674 | ||
Patient characteristics and severity of human rhinovirus infections in children | Q38124148 | ||
Translational research in pediatrics III: bronchoalveolar lavage | Q38225086 | ||
Inflammasomes and its importance in viral infections. | Q38971599 | ||
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features | Q38986306 | ||
Pharmacotherapeutic Considerations for Individuals with Down Syndrome | Q39032991 | ||
Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemic juvenile arthritis (CJA). | Q39413814 | ||
Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013. | Q39663220 | ||
Defective Lung Macrophages in Pulmonary Alveolar Proteinosis | Q40012602 | ||
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. | Q40101219 | ||
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. | Q40198507 | ||
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study | Q40241303 | ||
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis | Q40263864 | ||
Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review | Q40317853 | ||
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series | Q40335671 | ||
The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families | Q40546279 | ||
Morbidity and medication in a large population of individuals with Down syndrome compared to the general population | Q40634094 | ||
Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarization | Q41824496 | ||
The great mimickers: Castleman disease. | Q42210448 | ||
A 21-year-old man with systemic-onset juvenile rheumatoid arthritis, cough and progressive dyspnea. | Q42231947 | ||
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis | Q42508031 | ||
Genetic testing in children with surfactant dysfunction | Q43440530 | ||
Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation | Q43740939 | ||
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. | Q44645053 | ||
Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations | Q44680196 | ||
Familial interstitial disease with I73T mutation: A mid- and long-term study | Q44728463 | ||
Refined characterization and reference values of the pediatric T- and B-cell compartments | Q45191073 | ||
Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure | Q47725434 | ||
Mortality rates are increased in patients with systemic juvenile idiopathic arthritis. | Q48258658 | ||
IL-1α promotes pathogenic immature myeloid cells and IL-1β favors protective mature myeloid cells during acute lung infection. | Q49650563 | ||
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids | Q50180205 | ||
Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning | Q50421386 | ||
New interplay between interstitial and alveolar macrophages explains pulmonary alveolar proteinosis (PAP) induced by indium tin oxide particles. | Q52683960 | ||
IL-1α induces CD11blow alveolar macrophage proliferation and maturation during granuloma formation | Q56834530 | ||
Drug-Induced Interstitial Lung Disease: A Systematic Review | Q57463653 | ||
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries | Q60930184 | ||
Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience | Q61911597 | ||
Primary pulmonary hypertension in a patient with systemic-onset juvenile arthritis | Q67771315 | ||
Bronchoalveolar lavage studies in children without parenchymal lung disease: cellular constituents and protein levels | Q70921804 | ||
Diffuse progressive pulmonary interstitial and intra-alveolar cholesterol granulomas in childhood | Q71841452 | ||
Clinical, radiological and pathological features of ABCA3 mutations in children | Q79909696 | ||
Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug | Q80133101 | ||
Pulmonary alveolar proteinosis in pediatric leukemia | Q80214199 | ||
Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome | Q85901996 | ||
Comments on: DRESS syndrome | Q86087419 | ||
Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects | Q90925974 | ||
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come? | Q91083949 | ||
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study | Q92219527 | ||
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors | Q92399558 | ||
Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases | Q92661176 | ||
P433 | issue | 12 | |
P921 | main subject | lung disease | Q3392853 |
P304 | page(s) | 1722-1731 | |
P577 | publication date | 2019-09-27 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Emergent high fatality lung disease in systemic juvenile arthritis | |
P478 | volume | 78 |
Q90709366 | Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? |
Q89564969 | Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases |
Q97568272 | Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019 |
Q96647317 | Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm |
Q90661480 | Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis |
Search more.